Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 4381 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Journey Medical Corporation

Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  PharmAla Biotech

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aur

Read more ››
By: GlobeNewswire - 18 Mar 2024

T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  T2 Biosystems, Inc.

Inside Information: Additional Positive Data from the Phase 1 Part of the BEXMAB Study in Both Higher-Risk HMA-Failed MDS and r/r AML

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Faron Pharmaceuticals Oy

Parexel Announces CEO Succession Plan

Read more ››
By: GlobeNewswire - 18 Mar 2024

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Chromocell Therapeutics Corporation

Medigene AG to report full year 2023 financial results on March 28, 2024

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Medigene AG

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 18 Mar 2024

Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Novozymes A/S

RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit

Read more ››
By: GlobeNewswire - 18 Mar 2024

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Progyny, Inc.

TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  TaiMed Biologics Inc. | TaiMed Biologics, Inc.

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Daxor Corporation

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Daxor Corporation

Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Shenzhen Chipscreen Biosciences Co., Ltd.

Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Bio-Thera Solutions Co., Ltd.

RYBREVANT® (amivantamab-vmjw) data at ELCC advance Johnson & Johnson's ambition to transform the standard of care for patients with EGFR-mutated non-small cell lung cancer

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

CMUH(Taiwan) Using AI to Monitor Home Hemodialysis

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  China-Japan Friendship Hospital | Clinical Trial Center, China Medical University Hospital

WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  WuXi AppTec Co.,Ltd.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑